265 related articles for article (PubMed ID: 24943276)
1. A traditional Japanese medicine--Hangeshashinto (TJ-14)--alleviates chemoradiation-induced mucositis and improves rates of treatment completion.
Yamashita T; Araki K; Tomifuji M; Kamide D; Tanaka Y; Shiotani A
Support Care Cancer; 2015 Jan; 23(1):29-35. PubMed ID: 24943276
[TBL] [Abstract][Full Text] [Related]
2. Hangeshashinto improves the completion rate of chemoradiotherapy and the nutritional status in patients with head and neck cancer.
Hatakeyama H; Takahashi H; Oridate N; Kuramoto R; Fujiwara K; Homma A; Takeda H; Fukuda S
ORL J Otorhinolaryngol Relat Spec; 2015; 77(2):100-8. PubMed ID: 25896416
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
Harada K; Ferdous T; Horinaga D; Uchida K; Mano T; Mishima K; Park S; Hanazawa H; Takahashi S; Okita A; Fukunaga M; Maruta J; Kami N; Shibuya K; Ueyama Y
Support Care Cancer; 2016 Feb; 24(2):953-959. PubMed ID: 26248650
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis.
Aoyama T; Nishikawa K; Takiguchi N; Tanabe K; Imano M; Fukushima R; Sakamoto J; Oba MS; Morita S; Kono T; Tsuburaya A
Cancer Chemother Pharmacol; 2014 May; 73(5):1047-54. PubMed ID: 24652604
[TBL] [Abstract][Full Text] [Related]
5. Hangeshashinto (TJ-14) prevents radiation-induced mucositis by suppressing cyclooxygenase-2 expression and chemotaxis of inflammatory cells.
Kamide D; Yamashita T; Araki K; Tomifuji M; Shiotani A
Clin Transl Oncol; 2017 Nov; 19(11):1329-1336. PubMed ID: 28516399
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
Matsuda C; Munemoto Y; Mishima H; Nagata N; Oshiro M; Kataoka M; Sakamoto J; Aoyama T; Morita S; Kono T
Cancer Chemother Pharmacol; 2015 Jul; 76(1):97-103. PubMed ID: 25983022
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Benefit of Placentrex in the Management of Acute Chemo Radiation Induced Mucositis in Oral Cancer Patients.
Kondaveeti SS; C V D; John C; M M; S R
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3099-3103. PubMed ID: 30486548
[TBL] [Abstract][Full Text] [Related]
8. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effects of Adjuvant Melatonin in Minimizing Oral Mucositis Complications in Head and Neck Cancer Patients Receiving Concurrent Chemoradiation.
Onseng K; Johns NP; Khuayjarernpanishk T; Subongkot S; Priprem A; Hurst C; Johns J
J Altern Complement Med; 2017 Dec; 23(12):957-963. PubMed ID: 28657801
[TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment.
Lozano A; Marruecos J; Rubió J; Farré N; Gómez-Millán J; Morera R; Planas I; Lanzuela M; Vázquez-Masedo MG; Cascallar L; Giralt J; Escames G; Valentí V; Grima P; Bosser R; Tarragó C; Mesía R
Clin Transl Oncol; 2021 Sep; 23(9):1801-1810. PubMed ID: 33738704
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized pilot study of bioadhesive chlorhexidine gel in the prevention and treatment of mucositis induced by chemoradiotherapy of head and neck cancer.
Diaz-Sanchez RM; Pachón-Ibáñez J; Marín-Conde F; Rodríguez-Caballero Á; Gutierrez-Perez JL; Torres-Lagares D
Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e378-85. PubMed ID: 25662553
[TBL] [Abstract][Full Text] [Related]
12. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
13. The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care.
Lambrecht M; Mercier C; Geussens Y; Nuyts S
Support Care Cancer; 2013 Oct; 21(10):2663-70. PubMed ID: 23686379
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of an ayurvedic preparation of yashtimadhu (
Mamgain RK; Gupta M; Mamgain P; Verma SK; Pruthi DS; Kandwal A; Saini S
J Cancer Res Ther; 2020; 16(3):458-462. PubMed ID: 32719251
[TBL] [Abstract][Full Text] [Related]
15. [Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy].
Zhang XX; Ma L; Wang JL; Wu WM; Feng LC; Huang DL
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jun; 46(6):505-8. PubMed ID: 21924104
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
17. The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study.
Rao S; Dinkar C; Vaishnav LK; Rao P; Rai MP; Fayad R; Baliga MS
Integr Cancer Ther; 2014 May; 13(3):201-10. PubMed ID: 24165896
[TBL] [Abstract][Full Text] [Related]
18. Results of a randomized controlled phase III trial: efficacy of polyphenol-containing cystus® tea mouthwash solution for the reduction of mucositis in head and neck cancer patients undergoing external beam radiotherapy.
Ebert N; Kensche A; Löck S; Hadiwikarta WW; Hänsch A; Dörr W; Krause M; Hannig C; Baumann M
Strahlenther Onkol; 2021 Jan; 197(1):63-73. PubMed ID: 32970162
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma.
Liu YJ; Zhu GP; Guan XY
Oral Oncol; 2012 Jun; 48(6):554-9. PubMed ID: 22289637
[TBL] [Abstract][Full Text] [Related]
20. Benefits of immunonutrition in patients with head and neck cancer receiving chemoradiation: A phase II randomized, double-blind study.
Dechaphunkul T; Arundon T; Raungkhajon P; Jiratrachu R; Geater SL; Dechaphunkul A
Clin Nutr; 2022 Feb; 41(2):433-440. PubMed ID: 35007812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
